Resmed (RMD) Operating Leases (2019 - 2026)

Resmed (RMD) has 8 years of Operating Leases data on file, last reported at $149.8 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases rose 8.59% year-over-year to $149.8 million; the trailing twelve-month figure through Mar 2026 stood at $149.8 million (up 8.59% YoY), and the FY2025 full-year result was $153.0 million, up 8.18% from the prior year.
• Operating Leases for Q1 2026 stood at $149.8 million, down from $154.1 million in the prior quarter.
• Across five years, Operating Leases topped out at $154.1 million in Q4 2025 and bottomed at $112.4 million in Q3 2023.
• The 5-year median for Operating Leases is $138.0 million (2025), against an average of $133.4 million.
• The widest annual swing landed in 2022, when Operating Leases retreated 12.43%; it then advanced 28.49% in 2024.
• A 5-year view of Operating Leases shows it stood at $116.4 million in 2022, then rose by 20.79% to $140.6 million in 2023, then slipped by 1.06% to $139.2 million in 2024, then grew by 10.76% to $154.1 million in 2025, then retreated by 2.79% to $149.8 million in 2026.
• The last three Operating Leases figures came in at $149.8 million (Q1 2026), $154.1 million (Q4 2025), and $147.8 million (Q3 2025), per Business Quant data.

Peer Comparison